Physiopathologie

OASI related articles

Join our mailing list and never miss an update

In the context of the PRAISE e-cohort, we listed here scientific articles about OASI. This list is regularly updated.

Last update: January 29th, 2020

Feb 1, 2020

Immune-related Adverse Events Associated with Cancer Immunotherapy: A Review for the Practicing[...]

S. Jamal et al., 2020. Immune checkpoint inhibitors have revolutionized cancer therapy by blocking inhibitory pathways of the immune...

Dec 9, 2019

Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy

Kostine M et al., 2019 Compared with conventional cancer therapies, the spectrum of toxicities observed with checkpoint inhibitors is...

Oct 4, 2019

Testing Immune-Related Adverse Events in Cancer Immunotherapy

JR. Farmer, 2019. Immune-targeted therapeutics are being used in cancer. Immune "checkpoint inhibition" provides promise for prolonged...

Aug 15, 2019

Balancing cancer immunotherapy and immune-related adverse events: The emerging role [...]

T. Alissafi et al., 2019 Advances in our understanding οf tumor immunity have prompted a paradigm shift in oncology, with the emergence...

Jul 3, 2019

Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard [...]

Couey M.A et al., 2019 Background: The risk of delayed autoimmunity occurring months or years after discontinuation of immunotherapy is...

Jun 13, 2019

Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis

Salem JE et al., 2019 Immune checkpoint inhibitors are broadly active treatments for cancer, but they can result in immune-related...

Jan 24, 2019

Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with RA

Gottenberg JE et al., 2019 Objective To compare the effectiveness and safety of three non-tumour necrosis factor (TNF) α inhibitors...

Jan 18, 2019

Addressing immune-related adverse events of cancer immunotherapy: how prepared are rheumatologists?

Kostine M et al., 2019 Cancer immunotherapy blocking immune checkpoints represents a major advance in oncology. Immune checkpoint...

Jun 28, 2018

Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-Review From the Mela [...]

Kristina Buder-Bakhaya et al., 2018 Background: Immune checkpoint inhibition (ICI) with anti-CTLA-4 and/or anti-PD-1 antibodies is...

Jan 11, 2018

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

M.A Postow, R. Sidlow, M.D Hellmann, 2018. The wide range of immune-related adverse effects associated with immune checkpoint blockade...

Oct 10, 2017

Clinical features, predictive correlates, and pathophysiology of immune-related adverse events[...]

Jennifer M Yoest, 2017. Abstract: Identification and characterization of T-cell regulatory mechanisms, or checkpoints, have led to a wave...

Jun 9, 2017

Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor [...]

Belkhir R et al., 2017 Objectives: Immune checkpoint inhibitors (ICIs) targeting cytotoxic T-lymphocyte-associated protein 4 and...

Feb 15, 2017

Opportunistic autoimmunity secondary to cancer immunotherapy(OASI): An emerging challenge

M. Kostine, L. Chiche, E. Lazaro, P. Halfon, C. Charpin, D. Arniaud, F. Retornaz, P. Blanco, N. Jourde-Chiche, C. Richez, C. Stavris,...

Dec 1, 2016

Neurologic complications of immune checkpoint inhibitors

AF. Hottinger, 2016. In recent years, advances in the understanding of the regulatory mechanisms of the immune system has led to the...

Oct 24, 2016

The Safety of Therapeutic Monoclonal Antibodies: Implications for Cancer Therapy [...]

R. Demlova et al., 2016. Monoclonal antibody-based treatment of cancer has been established as one of the most successful therapeutic...

May 4, 2016

Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination

C. Boutros et al., 2016. Inhibition of immune checkpoints using anti-programmed cell death-1 (PD-1) or anti cytotoxic-T-lymphocyte-associ...

Feb 1, 2016

Immune-related adverse events with immune checkpoint blockade: a comprehensive review

JM. Michot et al,. 2016. Cancer immunotherapy is coming of age; it has prompted a paradigm shift in oncology, in which therapeutic agents...

Jan 14, 2016

Association of vitiligo with tumor response in patients with metastatic melanoma treated [...]

Camille Hua et al., 2016 IMPORTANCE Vitiligo is an autoimmune skin disorder that reacts against melanocytes. The association of vitiligo...

Mar 7, 2014

Endocrine-related adverse events following ipilimumab in patients with advanced melanoma [...]

M. Ryder et al., 2014. Novel immune checkpoint blockade with ipilimumab, an antibody blocking the cytotoxic T-lymphocyte antigen 4...